SUNNYVALE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical (SILK), Inc. , a company focused on reducing the risk of stroke and its devastating impact, today announced the launch of its ...

Silk Road Medical, Inc. SILK recently announced the launch of its ENROUTE Transcarotid Neuroprotection System PLUS (NPS PLUS), which is a key component of the company’s Transcarotid Artery ...

SUNNYVALE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the launch of ...

Studied across thousands of patients and supported by hundreds of clinical publications, the TCAR pioneer has continually delivered positive outcomes through minimally invasive techniques SUNNYVALE, ...

Boston Scientific Corp announced the acquisition of Silk Road Medical for $1.16 billion, valuing Silk Road Medical, Inc’s shares at $27.5, 27% higher than the previous share price. Boston Scientific ...

SUNNYVALE, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has ...